CHICAGO-(BUSINESS WIRE)-Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the company is scheduled to exhibit 4 abstracts at the American College of Cardiology (ACC) Annual Meeting, which convenes from March 29-31 in Chicago, Illinois. This is the first year that Tempus [...]
Tempus is an Illinois-based AI-enabled precision medicine firm that offers solutions such as data collaborations and biological modeling for the life sciences industry.